In vitro regulation of hepatocellular carcinoma cell viability, apoptosis, invasion, and AEG-1 expression by LY294002

Clinics and Research in Hepatology and Gastroenterology

Volumn 38, Issue 1, 2014, Pages 73-80

  Ma, Jian ^a   Xie, Shu Li ^a   Geng, Ya Jun ^a   Jin, Shuo ^a   Wang, Guang Yi ^a   Lv, Guo Yue ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CELL SURVIVAL; CHROMONES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MORPHOLINES; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED;

EID: 84893947169     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2013.06.012     Document Type: Article

References (42)

1. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132(7):2557-2576. [Epub 2007/06/16].
2. Lok A.S. Hepatitis B infection: pathogenesis and management. J Hepatol 2000, 32(1 Suppl.):89-97. [Epub 2000/03/23].
3. el-Serag H.B. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001, 5(1):87-107. [vi. Epub 2001/02/24].
4. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431(7007):461-466. [Epub 2004/08/27].
5. Emdad L., Sarkar D., Su Z.Z. Astrocyte Elevated Gene (AEG)-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther 2007, 114(2):155-215. [Epub 2008/05/01].
6. Lee S.G., Su Z.Z., Emdad L., Sarkar D., Franke T.F., Fisher P.B. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 2008, 27(8):1114-1121. [Epub 2007/08/21].
7. Schmidt C.M., McKillop I.H., Cahill P.A., Sitzmann J.V., Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem Biophys Res Commun 1997, 236(1):54-58. [Epub 1997/07/09].
8. McKillop I.H., Schmidt C.M., Cahill P.A., Sitzmann J.V. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma. Hepatology 1997, 26(6):1484-1491. [Epub 1997/12/16].
9. Thompson M.D., Monga S.P. WNT/beta-catenin signaling in liver health and disease. Hepatology 2007, 45(5):1298-1305. [Epub 2007/04/28].
10. Blum H.E. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol 2005, 11(47):7391-7400. [Epub 2006/01/27].
11. Song T.J., Ip E.W., Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004, 127(5 Suppl. 1):S248-S260. [Epub 2004/10/28].
12. Sala M., Fuster J., Llovet J.M., Navasa M., Sole M., Varela M., et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl 2004, 10(10):1294-1300. [Epub 2004/09/18].
13. Omata M., Tateishi R., Yoshida H., Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004, 127(5 Suppl. 1):S159-S166. [Epub 2004/10/28].
14. Su Z.Z., Chen Y., Kang D.C., Chao W., Simm M., Volsky D.J., et al. Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment. Gene 2003, 306:67-78. [Epub 2003/03/27].
15. Su Z.Z., Kang D.C., Chen Y., Pekarskaya O., Chao W., Volsky D.J., et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization. RaSH. Oncogene 2002, 21(22):3592-3602. [Epub 2002/05/29].
16. Brown D.M., Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004, 5(4):365-374. [Epub 2004/04/20].
17. Lee S.G., Jeon H.Y., Su Z.Z., Richards J.E., Vozhilla N., Sarkar D., et al. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 2009, 28(26):2476-2484. [Epub 2009/05/19].
18. Yoo B.K., Emdad L., Su Z.Z., Villanueva A., Chiang D.Y., Mukhopadhyay N.D., et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 2009, 119(3):465-477. [Epub 2009/02/18].
19. Song L., Li W., Zhang H., Liao W., Dai T., Yu C., et al. Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J Pathol 2009, 219(3):317-326. [Epub 2009/08/01].
20. Emdad L., Sarkar D., Lee S.G., Su Z.Z., Yoo B.K., Dash R., et al. Astrocyte elevated gene-1: a novel target for human glioma therapy. Mol Cancer Ther 2010, 9(1):79-88. [Epub 2010/01/08].
21. Song H., Li C., Li R., Geng J. Prognostic significance of AEG-1 expression in colorectal carcinoma. Int J Colorectal Dis 2010, 25(10):1201-1209. [Epub 2010/07/14].
22. Yu C., Chen K., Zheng H., Guo X., Jia W., Li M., et al. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009, 30(5):894-901. [Epub 2009/03/24].
23. Chen W., Ke Z., Shi H., Yang S., Wang L. Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression. Neoplasma 2010, 57(6):522-529. [Epub 2010/09/18].
24. Xu J.B., Wu H., He Y.L., Zhang C.H., Zhang L.J., Cai S.R., et al. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol 2011, 28(2):455-462. [Epub 2010/03/20].
25. Lee S.G., Su Z.Z., Emdad L., Sarkar D., Fisher P.B. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci U S A 2006, 103(46):17390-17395. [Epub 2006/11/08].
26. Ward S.G., Finan P. Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents. Curr Opin Pharmacol 2003, 3(4):426-434. [Epub 2003/08/07].
27. Solit D.B., Basso A.D., Olshen A.B., Scher H.I., Rosen N. Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol. Cancer Res 2003, 63(9):2139-2144. [Epub 2003/05/03].
28. Bader A.G., Kang S., Zhao L., Vogt P.K. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005, 5(12):921-929. [Epub 2005/12/13].
29. Sears R., Nuckolls F., Haura E., Taya Y., Tamai K., Nevins J.R. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 2000, 14(19):2501-2514. [Epub 2000/10/06].
30. Cheng A.L., Kang Y.K., Chen Z., Tsao C.J., Qin S., Kim J.S., et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009, 10(1):25-34. [Epub 2008/12/20].
31. Bates S., Peters G. Cyclin D1 as a cellular proto-oncogene. Semin Cancer Biol 1995, 6(2):73-82. [Epub 1995/04/01].
32. Lukas J., Bartkova J., Rohde M., Strauss M., Bartek J. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol 1995, 15(5):2600-2611. [Epub 1995/05/01].
33. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376(6535):66-70. [Epub 1995/07/06].
34. Kaipainen A., Korhonen J., Pajusola K., Aprelikova O., Persico M.G., Terman B.I., et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med 1993, 178(6):2077-2088. [Epub 1993/12/01].
35. Peters K.G., De Vries C., Williams L.T. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A 1993, 90(19):8915-8919. [Epub 1993/10/01].
36. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P., Risau W., et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72(6):835-846. [Epub 1993/03/26].
37. Liotta L.A. Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 1986, 46(1):1-7. [Epub 1986/01/01].
38. Forster S.J., Talbot I.C., Critchley D.R. Laminin and fibronectin in rectal adenocarcinoma: relationship to tumour grade, stage and metastasis. Br J Cancer 1984, 50(1):51-61. [Epub 1984/07/01].
39. Albrechtsen R., Nielsen M., Wewer U., Engvall E., Ruoslahti E. Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res 1981, 41(12 Pt 1):5076-5081. [Epub 1981/12/01].
40. Charpin C., Lissitzky J.C., Jacquemier J., Lavaut M.N., Kopp F., Pourreau-Schneider N., et al. Immunohistochemical detection of laminin in 98 human breast carcinomas: a light and electron microscopic study. Hum Pathol 1986, 17(4):355-365. [Epub 1986/04/01].
41. Barsky S.H., Siegal G.P., Jannotta F., Liotta L.A. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 1983, 49(2):140-147. [Epub 1983/08/01].
42. Mathur V., Satrawala Y., Rajput M.S., et al. Solid lipid nanoparticles in cancer therapy. Int J Drug Delivery 2010, 2:192-199.